These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38382852)

  • 1. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis.
    Meucci MC; Lillo R; Mango F; Marsilia M; Iannaccone G; Tusa F; Luigetti M; Biagini E; Massetti M; Lanza GA; Lombardo A; Graziani F
    Int J Cardiol; 2024 May; 402():131891. PubMed ID: 38382852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy.
    Boyd AC; Lo Q; Devine K; Tchan MC; Sillence DO; Sadick N; Richards DA; Thomas L
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1415-23. PubMed ID: 24094560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease.
    Rausch K; Scalia GM; Sato K; Edwards N; Lam AK; Platts DG; Chan J
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):81-90. PubMed ID: 32728989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Left Atrial Function in Fabry Disease: A Longitudinal Speckle-Tracking Echocardiography Study.
    Pichette M; Serri K; Pagé M; Di LZ; Bichet DG; Poulin F
    J Am Soc Echocardiogr; 2017 Feb; 30(2):170-179.e2. PubMed ID: 27939050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial structure and function in cardiac amyloidosis.
    Nochioka K; Quarta CC; Claggett B; Roca GQ; Rapezzi C; Falk RH; Solomon SD
    Eur Heart J Cardiovasc Imaging; 2017 Oct; 18(10):1128-1137. PubMed ID: 28637305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements.
    Shanks M; Thompson RB; Paterson ID; Putko B; Khan A; Chan A; Becher H; Oudit GY
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1407-14. PubMed ID: 24125876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy　- Comparative Strain Imaging Study.
    de Gregorio C; Dattilo G; Casale M; Terrizzi A; Donato R; Di Bella G
    Circ J; 2016 Jul; 80(8):1830-7. PubMed ID: 27350016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart and left atrial strain to differentiate cardiac amyloidosis and Fabry disease.
    Mattig I; Steudel T; Klingel K; Barzen G; Frumkin D; Spethmann S; Romero Dorta E; Stangl K; Heidecker B; Landmesser U; Knebel F; Canaan-Kühl S; Hahn K; Brand A
    Sci Rep; 2024 Jan; 14(1):2445. PubMed ID: 38291191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global cardiac alterations detected by speckle-tracking echocardiography in Fabry disease: left ventricular, right ventricular, and left atrial dysfunction are common and linked to worse symptomatic status.
    Morris DA; Blaschke D; Canaan-Kühl S; Krebs A; Knobloch G; Walter TC; Haverkamp W
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):301-13. PubMed ID: 25315709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Left Atrial Deformation Parameters and Their Prognostic Impact in Patients with Pathological Left Ventricular Hypertrophy: Analysis by Speckle Tracking Echocardiography.
    Iio C; Inoue K; Nishimura K; Fujii A; Nagai T; Suzuki J; Okura T; Higaki J; Ogimoto A
    Echocardiography; 2015 Dec; 32(12):1821-30. PubMed ID: 25959698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in left atrial myocardial dynamics during reservoir phase between hypertrophic cardiomyopathy and hypertensive heart determined using three-dimensional speckle tracking echocardiography.
    Yanagi Y; Okada K; Kaga S; Mikami T; Aiba M; Masauzi N; Murayama M; Tanemura A; Yokoyama S; Nishino H; Nakabachi M; Tamaki Y; Aoyagi H; Motoi K; Ishizaka S; Chiba Y; Tsujinaga S; Iwano H; Anzai T
    Int J Cardiovasc Imaging; 2022 Aug; 38(8):1781-1791. PubMed ID: 37726515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phasic left atrial strain analysis to discriminate cardiac amyloidosis in patients with unclear thick heart pathology.
    Brand A; Frumkin D; Hübscher A; Dreger H; Stangl K; Baldenhofer G; Knebel F
    Eur Heart J Cardiovasc Imaging; 2021 May; 22(6):680-687. PubMed ID: 32243500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy.
    Meucci MC; Lillo R; Lombardo A; Lanza GA; Bootsma M; Butcher SC; Massetti M; Manna R; Bax JJ; Crea F; Ajmone Marsan N; Graziani F
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):542-551. PubMed ID: 35900225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe bradyarrhythmia linked to left atrial dysfunction in Fabry disease-A cross-sectional study.
    Di LZ; Pichette M; Nadeau R; Bichet DG; Poulin F
    Clin Cardiol; 2018 Sep; 41(9):1207-1213. PubMed ID: 29959806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of myocardial work in patients with left ventricular hypertrophy.
    Fan J; Ma C; Wang H; Zhou B
    Int J Cardiovasc Imaging; 2023 Jun; 39(6):1105-1113. PubMed ID: 36922462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of phasic left atrial strain and left ventricular posterolateral strain pattern to discriminate Fabry cardiomyopathy from other forms of left ventricular hypertrophy.
    Frumkin D; Mattig I; Laule N; Al Daas M; Canaan-Kühl S; Knebel F; Stangl K; Brand A
    Echocardiography; 2021 Nov; 38(11):1870-1878. PubMed ID: 34672387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study.
    Liu XH; Shi JY; Zhang DD; Jia FW; Lin X; Zhu YL; Zhuang JL; Fang LG; Chen W
    BMC Cardiovasc Disord; 2022 Apr; 22(1):175. PubMed ID: 35428181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
    Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
    Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.